Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

COVID-19 death toll touches 1,694; cases rise to 49,391

by AIP Online Bureau | May 6, 2020 | Disaster & Management, Eco/Invest/Demography, Health, Indian News

  New Delhi:  The death toll due to COVID-19 rose to 1,694 and the number of cases climbed to 49,391 in the country on Wednesday, registering an increase of 126 deaths and 2,958 cases in the last 24 hours, the Union Health Ministry said.   The number of...

Israel isolates coronavirus antibody in ‘significant breakthrough’:Minister

by AIP Online Bureau | May 6, 2020 | Disaster & Management, Eco/Invest/Demography, Facts, Health

  JERUSALEM: Israel has isolated a key coronavirus antibody at its main biological research laboratory, the Israeli defence minister said on Monday, calling the step a "significant breakthrough" toward a possible treatment for the coronavirus pandemic....

BBB to interview 5 sr GMs on May 11 to select CMD of Orientel Insurance

by AIP Online Bureau | May 6, 2020 | Indian News, Non-Life, Policy

  New Delhi: Even as the much awaited merger of the three public sector general insurance companies-Oriental Insurance Company(OIC), United India Insurance(UII),National Insurance Company- has been further delayed beyond Apr 1, 2020,the...

‘No security breach in Aarogya Setu App’: Govt assures after ethical hacker raises privacy concerns

by AIP Online Bureau | May 6, 2020 | Disaster & Management, Eco/Invest/Demography, Health, Indian News, Technology

  New Delhi: The government on Wednesday said no data or security breach has been identified in Aarogya Setu after an ethical hacker raised concerns that the data of millions of people was at risk.   The app is the government's mobile application for...

Gilead in talks to expand global supply of COVID-19 drug remdesivir

by AIP Online Bureau | May 6, 2020 | Disaster & Management, Eco/Invest/Demography, Health, International News

  Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.   The drugmaker did not disclose details...
« Older Entries
Next Entries »

Recent Posts

  • SC orders SIT to name NIC CMD in FIR for probing criminal lapses in a motor accident fraud claim case
  • MP urges Sitharaman for easing ‘stringent’ lapse rules in life, health policies in Rajaya Sabha
  • Apr1 Renewals:India’s loss-free excess of loss business saw price reductions exceeding 20%, says Guy Carpenter
  • HDFC Life partnership with KKR for IPL cricket season
  • Peak Re ends 2025 with a $2.2 billion gross premium and net profit of $189 million

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy